CATALYST PHARMACEUTICALS, INC. Earnings Per Share Diluted

Quick Answer

CATALYST PHARMACEUTICALS, INC. reported Earnings Per Share Diluted of $1.68 per share for the year ending 2025.

  • CATALYST PHARMACEUTICALS, INC. showed an increase of +28.2% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from CATALYST PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), CATALYST PHARMACEUTICALS, INC.'s Earnings Per Share Diluted has grown by 609.1%.
  • Historical annual values: Fiscal year 2025: $1.68 per share | Fiscal year 2024: $1.31 per share | Fiscal year 2023: $0.63 per share | Fiscal year 2022: $0.75 per share | Fiscal year 2021: $0.37 per share | Fiscal year 2020: $0.71 per share | Fiscal year 2019: $0.30 per share | Fiscal year 2018: $0.33 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: